Back
[Use of synthetic slings and mesh implants in the treatment of female stress urinary incontinence and prolapse : Statement of the Working Group on Urological Functional Diagnostics and Female Urology of the Academy of the German Society of Urology].
Journal article

[Use of synthetic slings and mesh implants in the treatment of female stress urinary incontinence and prolapse : Statement of the Working Group on Urological Functional Diagnostics and Female Urology of the Academy of the German Society of Urology].

  • Höfner K Urologische Klinik, Evangelisches Krankenhaus Oberhausen, Virchowstr. 20, 46047, Oberhausen, Deutschland. klaus.hoefner@gmx.de.
  • Hampel C Urologische Abteilung, Marien-Hospital Erwitte, Erwitte, Deutschland.
  • Kirschner-Hermanns R Neuro-Urologie/Urologie Universitätsklinikum Bonn und Neuro-Urologie, Neurologisches Rehabilitationszentrum der Godeshöhe e. V., Bonn, Deutschland.
  • Alloussi SH Abteilung Urologie, Universitätsspital Basel, Basel, Schweiz.
  • Bauer RM Urologische Klinik und Poliklinik der Ludwig-Maximilians-Universität München, Campus Großhadern, München, Deutschland.
  • Bross S Urologische Klinik, Fürst-Stirum-Klinik Bruchsal, Bruchsal, Deutschland.
  • Bschleipfer T Klinik für Urologie, Andrologie und Kinderurologie, Klinikum Weiden/Kliniken Nordoberpfalz AG, Weiden i. d. Oberpfalz, Deutschland.
  • Goepel M Klinik für Urologie und Nephrologie, Helios Klinikum Niederberg, Velbert, Deutschland.
  • Haferkamp A Urologische Klinik und Poliklinik, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Deutschland.
  • Hüsch T Urologische Klinik und Poliklinik, Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz, Deutschland.
  • Kaufmann A Zentrum für Kontinenz und Neuro-Urologie, Kliniken Maria Hilf GmbH Mönchengladbach, Mönchengladbach, Deutschland.
  • Kiss G Institution Neuro-Urologische Ambulanz, Univ. Klinik f. Urologie Innsbruck, Innsbruck, Österreich.
  • Kranz J St.-Antonius Hospital, Klinik für Urologie und Kinderurologie Eschweiler, Eschweiler, Deutschland.
  • Oelke M Klinik für Urologie, Kinderurologie und Urologische Onkologie, St. Antonius-Hospital Gronau, Gronau, Deutschland.
  • Pannek J Neuro-Urologie, Schweizer Paraplegiker-Zentrum Nottwil, Nottwil, Schweiz.
  • Reitz A KontinenzZentrum Hirslanden Zürich, Zürich, Schweiz.
  • Rutkowski M Urologische Klinik, Landesklinikum Korneuburg, Korneuburg, Österreich.
  • Schäfer W , Sarasota, FL, USA.
  • Schulte-Baukloh H Urologie Turmstraße (Gemeinschaftspraxis), Berlin Mitte/Moabit, Deutschland.
  • Schumacher S Urology Department, Healthpoint Hospital, Abu Dhabi, Vereinigte Arabische Emirate.
  • Seif C Urologiezentrum Alter Markt, Kiel, Deutschland.
  • Schultz-Lampel D Kontinenzzentrum Südwest, Schwarzwald-Baar Klinikum Villingen-Schwenningen, Villingen-Schwenningen, Deutschland.
Show more…
  • 2019-11-20
Published in:
  • Der Urologe. Ausg. A. - 2020
Midurethral slings
Prolapse
Safety alert
Stress urinary incontinence
Vaginal meshes
Female
Germany
Humans
Pelvic Organ Prolapse
Suburethral Slings
Surgical Mesh
Urinary Incontinence, Stress
Urologic Surgical Procedures
English Due to a safety alert issued by the US Food and Drug Administration (FDA) in 2011 for transvaginal mesh implants to treat female prolapse as a result of numerous reports of complications such as infection, chronic pain, dyspareunia, vaginal erosion, shrinkage and erosion into other organs nearly all industrial products have been withdrawn from the market in the meantime. The United Kingdom, Australia, and New Zealand extended warnings and prohibitions even on the implantation of midurethral slings (TVT, TOT). In view of these current international controversies regarding the use of implanted materials for the treatment of stress incontinence and prolapse and the lack of clear guidelines for the use of biomaterials, the opinion of the Working Group on Urological Functional Diagnostics and Female Urology should provide clarity. The Opinion is based on the SCENIHR Report of the "European Commission's Scientific Committee on Emerging and Newly Identified Health Risks", the "Consensus Statement of the European Urology Association and the European Urogynaecological Association on the Use of Implanted Materials for Treating Pelvic Organ Prolapse and Stress Urinary Incontinence" and in compliance with relevant EAU and national guidelines and the opinion of the Association for Urogynaecology and Plastic Pelvic Floor Reconstruction (AGUB eV). In addition, recommendations are given for the future handling of implants of slings and meshes for the treatment of stress incontinence and prolapse from a urologic viewpoint.
Language
  • English
Open access status
closed
Identifiers
Persistent URL
https://sonar.ch/global/documents/150273
Statistics
Document views: 52 File downloads: